Try our beta test site
1 study found for:    11114638 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Intervention: Drug: EYE001

Study has passed its completion date and status has not been verified in more than two years.